Compliance to MADIT and MUSTT criteria for implantable cardioverter defibrillator therapy in the pre-SCD-Heft and MADIT II era. Data from a multicenter Italian study.
The follow-up of 1440 consecutive post-MI patients (68.9 ± 10.9 years) with an LVEF ≤ 40% was analyzed in 19 Italian hospitals to evaluate how many patients with clinical nonsustained VT and inducible sustained VT or VF underwent post-discharge risk assessment (RA). During 38 (range, 4-76) months follow-up, 611 patients (42.4%) qualified for and 294 (20.4%) effectively underwent RA combining LVEF assessment and Holter monitoring, 29 (2.0%) subsequently underwent programmed electrical stimulation and 19 (1.3%) received an ICD.
Cappato
Riccardo
R
Zanotto
Gabriele
G
Menozzi
Carlo
C
Coppola
Antonio
A
Curnis
Antonio
A
Freggiaro
Valerio
V
Sanna
Tommaso
T
Sinagra
Gianfranco
G
Pizzetti
Fabrizio
F
Sermasi
Sergio
S
Locatelli
Alessandro
A
Zaccone
Gabriele
G
Pecora
Domenico
D
Raciti
Giovanni
G
Accardi
Francesco
F
D000369:Aged, 80 and over; D002986:Clinical Trials as Topic; D017147:Defibrillators, Implantable / Q000592:standards*; D019983:Guideline Adherence; D006801:Humans; D007558:Italy; D009203:Myocardial Infarction / Q000628:therapy*; D013610:Tachycardia / Q000628:therapy